Last reviewed · How we verify
NCT00164151
A Comparison of the Efficacy and Safety of Two Bowel Preparations: HalfLytely® (2L NuLYTELY and 20 mg Bisacodyl), and Visicol™ Prior To Colonoscopy.
Phase 3 trial testing HalfLytely in Colonoscopy in 60 participants. Completed.
1 May 2002
Quick facts
| Lead sponsor | Braintree Laboratories |
|---|---|
| Phase | Phase 3 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | factorial |
| Masking | single |
| Enrollment | 60 |
| Start date | 1 June 2001 |
| Primary completion | 1 May 2002 |
| Sites | 1 location across United States |
Drugs / interventions tested
- HalfLytely (BISACODYL) — full drug profile →
- Visicol — full drug profile →
Conditions studied
- Colonoscopy — all drugs for Colonoscopy →
Sponsor
Braintree Laboratories — full company profile →
Who can join
18 and older, any sex, with Colonoscopy.
What's being measured
Primary outcomes are the specific endpoints the trial is designed to prove or disprove.
- Bowel preparation success: preparation rated as "good" or "excellent" by the blinded investigator.
Sponsor's own description
The objective of this study is to determine the efficacy and safety of HalfLytely as compared to Visicol as bowel preparations before colonoscopic examination.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Drug and Clinical Candidate Drug Data in ChEMBL.
Hunter FMI, Ioannidis H, Bento AP, Bosc N, et al · · 2025 · cited 3× · PMID 40971497 · DOI 10.1021/acs.jmedchem.5c00920
Verify or expand the search:
- PubMed search for NCT00164151
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Colonoscopy
Currently open trials in the same condition.
- NCT07353853 — Pre-packaged Low-residue Diet for Bowel Preparation in Patients With Inflammatory Bowel Disease · NA · recruiting
- NCT07335705 — Analysis of Factors Influencing the Quality of Bowel Preparation Before Colonoscopy in IBD Patients · recruiting
- NCT06763705 — Comparison of Safety and Efficacy for Different Sedation Regimens During Colonoscopy · Phase 4 · recruiting
- NCT07171853 — The Carbon Footprint Study of Colonoscopy · recruiting
- NCT07355777 — Video Tutorial and Oral Explanation Vs Oral Explanation Alone in Colonoscopy Preparation · NA · recruiting
Other Braintree Laboratories trials
Trials by the same sponsor.
- NCT05890001 — A Study to Evaluate the Long-Term Safety of BLI5100 in Patients With Gastroesophageal Reflux Disease · Phase 3 · completed
- NCT05587309 — A Study to Evaluate the Efficacy and Safety of BLI5100 in Patients With Erosive Esophagitis · Phase 3 · completed
- NCT05587322 — A Study to Evaluate the Efficacy and Safety of BLI5100 in Patients With Non-Erosive Reflux Disease · Phase 3 · completed
- NCT04446312 — Study 302: BLI4900 Versus an FDA-approved Comparator in Adult Subjects Prior to Colonoscopy · Phase 3 · completed
- NCT04446299 — Study 301: BLI4900 Versus an FDA-approved Comparator in Adult Subjects Prior to Colonoscopy · Phase 3 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT00164151 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Braintree Laboratories
- Last refreshed: 6 February 2013
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00164151.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing